Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 672

1.

Comparing Primary Prevention Recommendations: A Focused Look at United States and European Guidelines on Dyslipidemia.

Stone NJ, Blumenthal RS, Lloyd-Jones D, Grundy SM.

Circulation. 2020 Apr 7;141(14):1117-1120. doi: 10.1161/CIRCULATIONAHA.119.044562. Epub 2020 Apr 6. No abstract available.

PMID:
32250697
2.

Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia.

Virani SS, Smith SC Jr, Stone NJ, Grundy SM.

Circulation. 2020 Apr 7;141(14):1121-1123. doi: 10.1161/CIRCULATIONAHA.119.044282. Epub 2020 Apr 6. No abstract available.

PMID:
32250694
3.

The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: Looking at past, present and future.

Stone NJ, Grundy SM.

Prog Cardiovasc Dis. 2019 Sep - Oct;62(5):375-383. doi: 10.1016/j.pcad.2019.11.005. Epub 2019 Nov 13. Review.

PMID:
31733217
4.

Treating Hypercholesterolemia in Older Adults.

Forman DE, Stone NJ, Grundy SM.

JAMA. 2019 Aug 20;322(7):695. doi: 10.1001/jama.2019.8803. No abstract available.

PMID:
31429891
5.

Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines.

Virani SS, Akeroyd JM, Smith SC Jr, Al-Mallah M, Maddox TM, Morris PB, Petersen LA, Ballantyne CM, Grundy SM, Stone NJ.

J Am Coll Cardiol. 2019 Aug 6;74(5):712-714. doi: 10.1016/j.jacc.2019.05.051. No abstract available.

PMID:
31370962
6.

Current trends in non-HDL cholesterol and LDL cholesterol levels in adults with atherosclerotic cardiovascular disease.

Vega GL, Grundy SM.

J Clin Lipidol. 2019 Jul - Aug;13(4):563-567. doi: 10.1016/j.jacl.2019.05.012. Epub 2019 May 27.

7.

Elevated apolipoprotein B as a risk-enhancing factor in 2018 cholesterol guidelines.

Grundy SM, Stone NJ.

J Clin Lipidol. 2019 May - Jun;13(3):356-359. doi: 10.1016/j.jacl.2019.05.009. No abstract available.

PMID:
31229022
8.

2018 Cholesterol Clinical Practice Guidelines: Synopsis of the 2018 American Heart Association/American College of Cardiology/Multisociety Cholesterol Guideline.

Grundy SM, Stone NJ; Guideline Writing Committee for the 2018 Cholesterol Guidelines.

Ann Intern Med. 2019 Jun 4;170(11):779-783. doi: 10.7326/M19-0365. Epub 2019 May 28.

PMID:
31132793
9.

2018 American Heart Association/American College of Cardiology/Multisociety Guideline on the Management of Blood Cholesterol-Secondary Prevention.

Grundy SM, Stone NJ.

JAMA Cardiol. 2019 Jun 1;4(6):589-591. doi: 10.1001/jamacardio.2019.0911. No abstract available.

PMID:
30994869
10.

2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol: Primary Prevention.

Grundy SM, Stone NJ.

JAMA Cardiol. 2019 May 1;4(5):488-489. doi: 10.1001/jamacardio.2019.0777. No abstract available.

PMID:
30969322
11.

Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol.

Chuzi S, Pfenniger A, Lloyd-Jones DM, Blumenthal RS, Smith SC Jr, Virani SS, Grundy SM, Stone NJ.

JAMA Cardiol. 2019 May 1;4(5):473-477. doi: 10.1001/jamacardio.2019.0771.

PMID:
30969319
12.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J.

Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10. No abstract available. Erratum in: Circulation. 2019 Jun 18;139(25):e1182-e1186.

PMID:
30586774
13.

Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.

Abdullah SM, Defina LF, Leonard D, Barlow CE, Radford NB, Willis BL, Rohatgi A, McGuire DK, de Lemos JA, Grundy SM, Berry JD, Khera A.

Circulation. 2018 Nov 20;138(21):2315-2325. doi: 10.1161/CIRCULATIONAHA.118.034273.

PMID:
30571575
14.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J.

Circulation. 2019 Jun 18;139(25):e1046-e1081. doi: 10.1161/CIR.0000000000000624. Epub 2018 Nov 10. No abstract available. Erratum in: Circulation. 2019 Jun 18;139(25):e1178-e1181.

PMID:
30565953
15.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J.

J Am Coll Cardiol. 2019 Jun 25;73(24):e285-e350. doi: 10.1016/j.jacc.2018.11.003. Epub 2018 Nov 10. No abstract available. Erratum in: J Am Coll Cardiol. 2019 Jun 25;73(24):3237-3241.

PMID:
30423393
16.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, Goldberg R, Heidenreich PA, Hlatky MA, Jones DW, Lloyd-Jones D, Lopez-Pajares N, Ndumele CE, Orringer CE, Peralta CA, Saseen JJ, Smith SC Jr, Sperling L, Virani SS, Yeboah J.

J Am Coll Cardiol. 2019 Jun 25;73(24):3168-3209. doi: 10.1016/j.jacc.2018.11.002. Epub 2018 Nov 10. No abstract available. Erratum in: J Am Coll Cardiol. 2019 Jun 25;73(24):3234-3237.

PMID:
30423391
17.

Upper body fat predicts metabolic syndrome similarly in men and women.

Grundy SM, Williams C, Vega GL.

Eur J Clin Invest. 2018 Jul;48(7):e12941. doi: 10.1111/eci.12941. Epub 2018 May 15.

18.

Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome.

Boumosleh JM, Grundy SM, Phan J, Neeland IJ, Chang A, Vega GL.

J Endocr Soc. 2017 Nov 2;1(12):1417-1427. doi: 10.1210/js.2017-00323. eCollection 2017 Dec 1.

19.

An Analysis of Individual Body Fat Depots and Risk of Developing Cancer: Insights From the Dallas Heart Study.

Gupta A, Pandey A, Ayers C, Beg MS, Lakoski SG, Vega GL, Grundy SM, Johnson DH, Neeland IJ.

Mayo Clin Proc. 2017 Apr;92(4):536-543. doi: 10.1016/j.mayocp.2016.12.023. Epub 2017 Mar 11.

20.

Association of triglyceride-to-high density lipoprotein cholesterol ratio to cardiorespiratory fitness in men.

Vega GL, Grundy SM, Barlow CE, Leonard D, Willis BL, DeFina LF, Farrell SW.

J Clin Lipidol. 2016 Nov - Dec;10(6):1414-1422.e1. doi: 10.1016/j.jacl.2016.09.008. Epub 2016 Sep 17.

21.

Does Dietary Cholesterol Matter?

Grundy SM.

Curr Atheroscler Rep. 2016 Nov;18(11):68. Review.

PMID:
27739004
22.

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis.

Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS.

JAMA. 2016 Sep 27;316(12):1289-97. doi: 10.1001/jama.2016.13985. Review.

PMID:
27673306
23.

Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study.

Neeland IJ, Grundy SM, Li X, Adams-Huet B, Vega GL.

Nutr Diabetes. 2016 Jul 18;6(7):e221. doi: 10.1038/nutd.2016.28.

24.

Overnutrition, ectopic lipid and the metabolic syndrome.

Grundy SM.

J Investig Med. 2016 Aug;64(6):1082-6. doi: 10.1136/jim-2016-000155. Epub 2016 May 18. Review.

PMID:
27194746
25.

Scavenger Receptor B-1 Emerges as Anti-atherogenic Candidate.

Grundy SM.

Cell Metab. 2016 May 10;23(5):755-7. doi: 10.1016/j.cmet.2016.04.019.

26.

Fatty acid oxidation in normotriglyceridemic men.

Benjamin B, Wada Y, Grundy SM, Szuszkiewicz-Garcia M, Vega GL.

J Clin Lipidol. 2016 Mar-Apr;10(2):283-8. doi: 10.1016/j.jacl.2015.11.018. Epub 2015 Dec 2.

27.

Dyslipidaemia in 2015: Advances in treatment of dyslipidaemia.

Grundy SM.

Nat Rev Cardiol. 2016 Feb;13(2):74-5. doi: 10.1038/nrcardio.2015.208. Epub 2016 Jan 14. No abstract available.

PMID:
26763537
28.

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2.

Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, La Forge R, Daniels SR, Wilson DP, Morris PB, Wild RA, Grundy SM, Daviglus M, Ferdinand KC, Vijayaraghavan K, Deedwania PC, Aberg JA, Liao KP, McKenney JM, Ross JL, Braun LT, Ito MK, Bays HE, Brown WV, Underberg JA; NLA Expert Panel.

J Clin Lipidol. 2015 Nov-Dec;9(6 Suppl):S1-122.e1. doi: 10.1016/j.jacl.2015.09.002. Epub 2015 Sep 18. Erratum in: J Clin Lipidol. 2016 Jan-Feb;10(1):211. Underberg, James A [added].

29.

Metabolic syndrome update.

Grundy SM.

Trends Cardiovasc Med. 2016 May;26(4):364-73. doi: 10.1016/j.tcm.2015.10.004. Epub 2015 Oct 31. Review.

PMID:
26654259
30.

Cholesterol Efflux Capacity as a Therapeutic Target: Rationale and Clinical Implications.

Rohatgi A, Grundy SM.

J Am Coll Cardiol. 2015 Nov 17;66(20):2211-2213. doi: 10.1016/j.jacc.2015.09.012. No abstract available.

31.

The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome.

Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Després JP, Ndumele CE, Vijayaraghavan K, Handelsman Y, Puckrein GA, Araneta MR, Blum QK, Collins KK, Cook S, Dhurandhar NV, Dixon DL, Egan BM, Ferdinand DP, Herman LM, Hessen SE, Jacobson TA, Pate RR, Ratner RE, Brinton EA, Forker AD, Ritzenthaler LL, Grundy SM.

J Am Coll Cardiol. 2015 Sep 1;66(9):1050-67. doi: 10.1016/j.jacc.2015.06.1328. Review.

32.

Adipose tissue and metabolic syndrome: too much, too little or neither.

Grundy SM.

Eur J Clin Invest. 2015 Nov;45(11):1209-17. doi: 10.1111/eci.12519. Epub 2015 Sep 13. Review.

33.

Guidelines for the Management of High Blood Cholesterol.

Grundy SM, Feingold KR.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2019 Nov 30.

34.

Body fat distribution and incident cardiovascular disease in obese adults.

Neeland IJ, Turer AT, Ayers CR, Berry JD, Rohatgi A, Das SR, Khera A, Vega GL, McGuire DK, Grundy SM, de Lemos JA.

J Am Coll Cardiol. 2015 May 19;65(19):2150-1. doi: 10.1016/j.jacc.2015.01.061. No abstract available.

35.

National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV.

J Clin Lipidol. 2015 Mar-Apr;9(2):129-69. doi: 10.1016/j.jacl.2015.02.003. Epub 2015 Apr 7.

PMID:
25911072
36.

Reply: Statin dose based on limited evidence.

Smith SC Jr, Grundy SM.

J Am Coll Cardiol. 2015 Feb 24;65(7):760-1. doi: 10.1016/j.jacc.2014.11.042. No abstract available.

37.

Reply: statin-induced low low-density lipoprotein cholesterol level: is lower better?

Boekholdt SM, Hovingh GK, Waters DD, Grundy SM, Kastelein JJP.

J Am Coll Cardiol. 2015 Jan 6;65(1):109. doi: 10.1016/j.jacc.2014.10.021. No abstract available.

38.

Is There a Gradient of Mortality Risk among Men with Low Cardiorespiratory Fitness?

Farrell SW, Finley CE, Haskell WL, Grundy SM.

Med Sci Sports Exerc. 2015 Sep;47(9):1825-32. doi: 10.1249/MSS.0000000000000608.

PMID:
25551401
39.

Statins: definitive translational research.

Grundy SM.

Mol Med. 2014 Dec 16;20 Suppl 1:S20-3. doi: 10.2119/molmed.2014.00194. Review. No abstract available.

40.

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers.

Arsenault BJ, Barter P, DeMicco DA, Bao W, Preston GM, LaRosa JC, Grundy SM, Deedwania P, Greten H, Wenger NK, Shepherd J, Waters DD, Kastelein JJ; Treating to New Targets (TNT) Investigators.

PLoS One. 2014 Dec 22;9(12):e114519. doi: 10.1371/journal.pone.0114519. eCollection 2014.

41.

Statins for all?

Grundy SM.

Am J Cardiol. 2014 Nov 1;114(9):1443-6. doi: 10.1016/j.amjcard.2014.08.032. Epub 2014 Sep 4.

PMID:
25245412
42.

National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary.

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV.

J Clin Lipidol. 2014 Sep-Oct;8(5):473-88. doi: 10.1016/j.jacl.2014.07.007. Epub 2014 Jul 15.

43.

Cholesterol management in older persons.

Grundy SM.

Am J Med. 2014 Dec;127(12):1140-1. doi: 10.1016/j.amjmed.2014.07.037. Epub 2014 Aug 19. No abstract available.

PMID:
25149423
44.

2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol.

Smith SC Jr, Grundy SM.

J Am Coll Cardiol. 2014 Aug 12;64(6):601-12. doi: 10.1016/j.jacc.2014.06.1159. Review.

45.

Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.

Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, LaRosa JC, Waters DD, DeMicco DA, Simes RJ, Keech AC, Colquhoun D, Hitman GA, Betteridge DJ, Clearfield MB, Downs JR, Colhoun HM, Gotto AM Jr, Ridker PM, Grundy SM, Kastelein JJ.

J Am Coll Cardiol. 2014 Aug 5;64(5):485-94. doi: 10.1016/j.jacc.2014.02.615. Review.

46.

An assessment by the Statin Intolerance Panel: 2014 update.

Guyton JR, Bays HE, Grundy SM, Jacobson TA, The National Lipid Association Statin Intolerance Panel.

J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S72-81. doi: 10.1016/j.jacl.2014.03.002.

PMID:
24793444
47.

An assessment by the Statin Diabetes Safety Task Force: 2014 update.

Maki KC, Ridker PM, Brown WV, Grundy SM, Sattar N, The Diabetes Subpanel of the National Lipid Association Expert Panel.

J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S17-29. doi: 10.1016/j.jacl.2014.02.012.

PMID:
24793439
48.

Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.

Vega GL, Barlow CE, Grundy SM, Leonard D, DeFina LF.

J Investig Med. 2014 Feb;62(2):345-9. doi: 10.2310/JIM.0000000000000044.

PMID:
24402298
49.

Ethnic and gender susceptibility to metabolic risk.

Grundy SM, Neeland IJ, Turer AT, Vega GL.

Metab Syndr Relat Disord. 2014 Mar;12(2):110-6. doi: 10.1089/met.2013.0113. Epub 2013 Dec 10.

50.

An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia.

Expert Dyslipidemia Panel, Grundy SM.

J Clin Lipidol. 2013 Nov-Dec;7(6):561-5. doi: 10.1016/j.jacl.2013.10.001. Epub 2013 Oct 22. Review.

PMID:
24314355

Supplemental Content

Loading ...
Support Center